NEWS
June 30, 2010
Celgene to Buy Abraxis BioScience for $2.9 Billion
Celgene Corp agreed to acquire Abraxis BioScience Inc for $2.9 billion in cash and stock to expand its oncology pipeline, the companies said...
|
|
|
|
If you already have a OnePass account, you can use it to access Business Law Currents as part of our free trial
program. If you don’t have a OnePass account, click on the link to the left to create one. You can then use this
OnePass account to access Business Law Currents as part of our free trial.
|
|